Who has invested in Shenzhen Salubris Pharmaceuticals?

Shenzhen Salubris Pharmaceuticals Co., Ltd. are named among the investors backing Shenzhen Salubris Pharmaceuticals.

Shenzhen Salubris Pharmaceuticals Funding: $67M Raised

Shenzhen Salubris Pharmaceuticals funding overview

Shenzhen Salubris Pharmaceuticals has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for Shenzhen Salubris Pharmaceuticals runs through 2024; nothing later has been disclosed. Investors on record include Shenzhen Salubris Pharmaceuticals Co., Ltd..

Shenzhen Salubris Pharmaceuticals at a glance

Total raised: $67M
Latest round date: April 2024
Notable investors: Shenzhen Salubris Pharmaceuticals Co., Ltd.

Frequently asked about Shenzhen Salubris Pharmaceuticals funding

How much has Shenzhen Salubris Pharmaceuticals raised?: Shenzhen Salubris Pharmaceuticals has raised $67M in total disclosed funding across the rounds on record.
Who has invested in Shenzhen Salubris Pharmaceuticals?: Shenzhen Salubris Pharmaceuticals Co., Ltd. are named among the investors backing Shenzhen Salubris Pharmaceuticals.
What was the latest Shenzhen Salubris Pharmaceuticals funding round?: No round stage has been disclosed for Shenzhen Salubris Pharmaceuticals.
Where is Shenzhen Salubris Pharmaceuticals based?: No headquarters location is disclosed for Shenzhen Salubris Pharmaceuticals.
When did Shenzhen Salubris Pharmaceuticals last raise?: The last disclosed Shenzhen Salubris Pharmaceuticals round closed in April 2024.

We update the Shenzhen Salubris Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies and their backers are listed below.

Shenzhen Salubris Pharmaceuticals Funding: $67M Raised

Shenzhen Salubris Pharmaceuticals funding overview

Shenzhen Salubris Pharmaceuticals at a glance

Frequently asked about Shenzhen Salubris Pharmaceuticals funding

Companies related to Shenzhen Salubris Pharmaceuticals (30)

Browse related funding lists (2)